Uxin (UXIN) Cash & Equivalents (2016 - 2026)

Uxin (UXIN) has reported Cash & Equivalents for 11 consecutive years, with $6.9 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $6.9 million, down 51.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (down 51.8% YoY), and the FY2025 annual result was $11.9 million, up 245.06% from the prior year.
• Cash & Equivalents was $6.9 million for Q1 2026 at Uxin, down from $11.7 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.4 billion in Q3 2023 and troughed at $3424.0 in Q3 2022.
• Average Cash & Equivalents over 5 years is $149.6 million, with a median of $4.1 million recorded in 2024.
• Year-over-year, Cash & Equivalents plunged 99.99% in 2022 and soared 71183495.21% in 2023.
• Over 5 years, Cash & Equivalents stood at $15088.0 in 2022, then surged by 17711.98% to $2.7 million in 2023, then soared by 30.08% to $3.5 million in 2024, then jumped by 234.76% to $11.7 million in 2025, then slumped by 41.33% to $6.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $6.9 million in Q1 2026, $11.7 million in Q4 2025, and $10641.5 in Q3 2025.